
Shree Ganesh Remedies Falls to 52-Week Low of Rs.423 Amidst Continued Downtrend
2025-12-04 12:47:55Shree Ganesh Remedies has reached a new 52-week low of Rs.423, marking a significant decline in its stock price amid ongoing downward momentum. The pharmaceutical company’s shares have experienced a notable fall over recent sessions, reflecting a challenging period for the stock within the broader market context.
Read More
Shree Ganesh Rem Sees Revision in Market Evaluation Amidst Financial Challenges
2025-12-01 10:09:16Shree Ganesh Rem, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting recent financial and technical developments. The stock’s assessment has shifted following a series of quarterly results and market performance indicators that have drawn attention to its current standing within the sector.
Read More
Shree Ganesh Remedies Falls to 52-Week Low of Rs.442.1 Amidst Continued Downtrend
2025-11-25 12:48:09Shree Ganesh Remedies touched a fresh 52-week low of Rs.442.1 today, marking a significant decline in its stock price amid a sustained downward trend over recent sessions. The pharmaceutical company’s shares have been under pressure, reflecting a series of financial results and market dynamics that have influenced its valuation.
Read More
Shree Ganesh Remedies Hits New 52-Week Low at Rs. 450
2025-11-12 16:11:18Shree Ganesh Remedies has hit a new 52-week low, reflecting a significant downturn in its stock performance amid broader market trends. The company has seen a notable decline in profitability, with profits before and after tax decreasing substantially. Despite these challenges, it maintains a low debt to EBITDA ratio.
Read More
Shree Ganesh Remedies Hits New 52-Week Low at Rs. 455.1
2025-11-11 09:58:00Shree Ganesh Remedies has reached a new 52-week low, reflecting a challenging year with a significant decline in stock price. The company has reported negative results for the last three quarters, and its low Debt to EBITDA ratio indicates strong debt servicing ability, despite caution from institutional investors.
Read More
Shree Ganesh Remedies Hits New 52-Week Low at Rs. 455.1
2025-11-11 09:57:55Shree Ganesh Remedies has reached a new 52-week low, reflecting a challenging year with a significant decline in stock price. The company has reported negative results for the last three quarters, and its stock continues to underperform in the market, indicating ongoing difficulties in regaining investor confidence.
Read MoreWhy is Shree Ganesh Rem falling/rising?
2025-11-10 23:39:56As of 10-Nov, Shree Ganesh Remedies Ltd is experiencing a decline in its stock price, currently at Rs. 472.80, which reflects a decrease of Rs. 16.3 or 3.33%. The stock has hit a new 52-week low of Rs. 470 today and has been underperforming its sector by 4.38%. Over the past week, the stock has fallen by 3.60%, and it has seen a significant decline of 40.29% over the past year, indicating a troubling trend. The company has reported negative results for the last three consecutive quarters, with profits falling by 28.2%, which has contributed to a lack of investor confidence, as evidenced by the negligible domestic mutual fund holdings. In the broader market context, Shree Ganesh Remedies Ltd has underperformed compared to the benchmark index, with the Sensex showing a positive return of 6.91% year-to-date, while the stock has dropped 25.89% in the same period. This stark contrast highlights the stock's stru...
Read More
Shree Ganesh Remedies Hits New 52-Week Low at Rs. 470
2025-11-10 11:18:37Shree Ganesh Remedies has hit a new 52-week low, reflecting a challenging year with a significant decline in stock price. The company has underperformed its sector and reported negative results for three consecutive quarters, raising concerns about its financial health and investor confidence.
Read More
Shree Ganesh Remedies Hits New 52-Week Low at Rs. 470
2025-11-10 11:18:20Shree Ganesh Remedies has hit a new 52-week low, reflecting a challenging year with a significant stock price decline. The company has underperformed its sector and reported negative financial results for three consecutive quarters, raising concerns among investors despite a low debt-to-equity ratio.
Read MoreAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
16-Nov-2025 | Source : BSETranscript of Earnings Conference Call
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
12-Nov-2025 | Source : BSEAudio Recording - Earnings Call held on November 12 2025
Announcement under Regulation 30 (LODR)-Newspaper Publication
08-Nov-2025 | Source : BSENewspaper Publication
Corporate Actions
No Upcoming Board Meetings
Shree Ganesh Remedies Ltd has declared 5% dividend, ex-date: 07 Sep 23
No Splits history available
Shree Ganesh Remedies Ltd has announced 1:5 bonus issue, ex-date: 01 Nov 21
Shree Ganesh Remedies Ltd has announced 7:100 rights issue, ex-date: 03 Feb 23






